AI-Generated Control Arms in Clinical Trials: Evidence, Opportunities, and Strategic Considerations
Clinical trials are undergoing structural change. As therapies become more targeted and patient populations more fragmented, the traditional randomized controlled trial (RCT) is increasingly difficult to execute. This is particularly true in oncology, rare diseases, and precision medicine, where eligible...
